|
Volumn 9, Issue 4, 2000, Pages 281-287
|
One more case of the double standard: Discrepancies between drug information provided to Brazilian and american physicians
a
a
NONE
(Brazil)
|
Author keywords
Drug information; Drugs prescribing; Pharmaceutical marketing strategies
|
Indexed keywords
ACECLOFENAC;
ACETYLSALICYLIC ACID;
AMOXICILLIN;
AMPICILLIN;
ASCORBIC ACID;
BETAMETHASONE SODIUM PHOSPHATE;
CAPTOPRIL;
CARBAMAZEPINE;
CATAFLAN;
CEFACLOR;
CEFADROXIL;
CEFALEXIN;
CHLORTALIDONE;
CIPROSPAN;
CONJUGATED ESTROGEN;
DICLOFENAC;
DICLOFENAC POTASSIUM;
DIHYDROERGOTOXINE MESILATE;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
KETOPROFEN;
LINCOMYCIN;
LORAZEPAM;
MICROVILAR;
OMEPRAZOLE;
PARACETAMOL;
PIROXICAM;
SCOPOLAMINE BUTYL BROMIDE;
ARTICLE;
BRAZIL;
CARDIOTOXICITY;
DRUG CHOICE;
DRUG CONTRAINDICATION;
DRUG FORMULARY;
DRUG HYPERSENSITIVITY;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MARKETING;
DRUG MONITORING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
GASTROINTESTINAL TOXICITY;
HUMAN;
HYPOTENSION;
IMPOTENCE;
KIDNEY FAILURE;
MAJOR CLINICAL STUDY;
MEDICAL DECISION MAKING;
MEDICAL PRACTICE;
PHYSICIAN;
POLYURIA;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROTEINURIA;
PUBLICATION;
QUALITY CONTROL;
TACHYCARDIA;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
|
EID: 0033788721
PISSN: 10538569
EISSN: None
Source Type: Journal
DOI: 10.1002/1099-1557(200007/08)9:4<281::AID-PDS511>3.0.CO;2-0 Document Type: Article |
Times cited : (7)
|
References (33)
|